Cognetivity Neurosciences Ltd. operates as a technology company. The firm engages in the development of platforms for medical uses such as early detection and monitoring of cognitive impairment in neurodegenerative diseases. It uses visual stimulus based diagnostic test and artificial intelligence tools, such as Integrated Cognitive Assessment. The company was founded by Sina Habibi and Seyed-Mahdi Khaligh-Razavi on December 11, 2015 and is headquartered in Vancouver, Canada.
Sector:
Technology Services
Industry:
Packaged Software
Employees:
N/A
Frequently Asked Questions
What is the 52-week high for Cognetivity Neurosciences Ltd?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Cognetivity Neurosciences Ltd 52 week high is $0.01 as of February 25, 2026.